National Drug Strategy
National Drug Strategy

National Evaluation of Pharmacotherapies for Opioid Dependence - Report of Results and Recommendations - Monograph Series No 52

Print page  Decrease text size  Increase text size

This report provides the findings of the analyses of clinical trials of pharmacotherapies for opioid dependence conducted across Australia. The treatment categories are methadone maintenance, buprenorphine maintenance, LAAM maintenance, naltrexone treatment, rapid opioid detoxification with anaesthesia or sedation, outpatient detoxification using buprenorphine, conventional inpatient detoxification and conventional outpatient detoxification. The data reported herein include short-term outcomes of detoxification.

Report prepared by Richard P. Mattick, Erol Digiusto, Chris Doran, Susannah O’Brien, Marian Shanahan, Jo Kimber, Nicola Henderson, Courtney Breen, James Shearer, Jenny Gates, Anthony Shakeshaft, and NEPOD Trial Investigators
Published for Commonwealth Department of Health and Ageing
October 2004

National Evaluation of Pharmacotherapies for Opioid Dependence - Report of Results and Recommendations - Monograph Series No 52 (PDF 463 KB)

Page currency, Latest update: 01 November, 2004

Help with accessing large files

When accessing large files (over 500 KB in size), it is recommended that the following procedure be used:

  1. Click the link with the RIGHT mouse button
  2. Choose "Save Target As.../Save Link As..." depending on your browser
  3. Select an appropriate folder on a local drive to place the downloaded file

Attempting to open large files within the browser window (by left-clicking) may inhibit your ability to continue browsing while the document is opening and/or lead to system problems.

Help with accessing PDF documents

Get Acrobat ReaderTo view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. The Adobe Acrobat Reader is available free of charge from Adobe's website.

If you are having difficulty downloading the PDF document(s) please email nationaldrugstrategy@health.gov.au and we will arrange for an alternative format or a copy to be sent to you.